Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 401 entries
View as:

Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01900509 Org: User:
Start: 08/31/13 End: 05/31/16 Due: 05/31/17

Psychosocial Impact of Disclosing Cancer Predisposition Genetic Testing Results During Childhood

Phase: N/A Priority: Normal
NCT ID: NCT04848142 Org: User:
Start: 05/07/21 End: 10/13/23 Due: 10/13/24

Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02473523 Org: User:
Start: 06/30/15 End: 12/31/16 Due: 12/31/17

Planning Margin Requirements for Pediatric Radiation Oncology

Phase: N/A Priority: Normal
NCT ID: NCT00704613 Org: User:
Start: 03/31/08 End: 07/31/11 Due: 07/31/12

Characterization of the Patient Population With Galactosialidosis

Phase: N/A Priority: Normal
NCT ID: NCT01416467 Org: User:
Start: 02/08/12 End: 04/12/12 Due: 04/12/13

Development of the Pediatric Neurocognitive Functioning Questionnaire

Phase: N/A Priority: Normal
NCT ID: NCT03213431 Org: User:
Start: 07/12/17 End: 12/08/17 Due: 12/08/18

Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05952687 Org: User:
Start: 03/31/24 End: 08/31/32 Due: 08/31/33

Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01540175 Org: User:
Start: 03/31/12 End: 06/30/15 Due: 06/30/16

Talazoparib Plus Irinotecan With or Without Temozolomide in Children With Refractory or Recurrent Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02392793 Org: User:
Start: 03/25/15 End: 08/30/19 Due: 08/30/20

Implementing an Adolescent and Young Adult (AYA) mHealth Vaping Cessation Program Into Oncology Clinics

Phase: N/A Priority: Normal
NCT ID: NCT05967585 Org: User:
Start: 08/04/23 End: 04/05/27 Due: 04/05/28

Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool

Phase: N/A Priority: Normal
NCT ID: NCT01152268 Org: User:
Start: 07/31/10 End: 06/30/14 Due: 06/30/15

Predictors and Outcomes in Patients With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT03431935 Org: User:
Start: 07/31/18 End: 01/31/26 Due: 01/31/27

Prevention of Oral Mucositis Using Photobiomodulation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04227340 Org: User:
Start: 02/04/20 End: 05/30/21 Due: 05/30/22

Childhood Cancer Survivors' Affective Response to Exercise

Phase: N/A Priority: Normal
NCT ID: NCT05763290 Org: User:
Start: 03/22/23 End: 12/31/25 Due: 12/31/26

Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT03276702 Org: User:
Start: 12/13/17 End: 07/31/19 Due: 07/31/20

A Pilot Study of Influenza Viruses Isolated From Immunocompromised Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT02352389 Org: User:
Start: 03/30/15 End: 12/08/22 Due: 12/08/23

Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02419755 Org: User:
Start: 04/14/15 End: 12/31/16 Due: 12/31/17

Molecular Analysis Of Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01050296 Org: User:
Start: 02/10/10 End: 09/30/25 Due: 09/30/26

Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT00186810 Org: User:
Start: 12/31/92 End: 10/31/07 Due: 10/31/08

Genetic Study of Familial Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT03067584 Org: User:
Start: 05/09/17 End: 06/23/17 Due: 06/23/18

Integration of mHEALTH Into the Care of Patients With Sickle Cell Disease to Increase Hydroxyurea Utilization

Phase: N/A Priority: Normal
NCT ID: NCT04080167 Org: User:
Start: 11/11/19 End: 08/31/22 Due: 08/31/23

Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG)

Phase: N/A Priority: Normal
NCT ID: NCT01644773 Org: User:
Start: 11/27/12 End: 09/28/18 Due: 09/28/19

Avian Influenza Studies In Lebanon

Phase: N/A Priority: Normal
NCT ID: NCT01107262 Org: User:
Start: 07/31/09 End: 12/31/10 Due: 12/31/11

AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or Prednisone

Phase: N/A Priority: Normal
NCT ID: NCT00719147 Org: User:
Start: 07/31/01 End: 07/31/05 Due: 07/31/06

PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma

Phase: N/A Priority: Normal
NCT ID: NCT01393912 Org: User:
Start: 07/31/11 End: 10/31/16 Due: 10/31/17